Cargando…

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors

Increasing knowledge of intertumor heterogeneity, intratumor heterogeneity, and cancer evolution has improved the understanding of anticancer treatment resistance. A better characterization of cancer evolution and subsequent use of this knowledge for personalized treatment would increase the chance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Anyue, Moes, Dirk Jan A.R., van Hasselt, Johan G.C., Swen, Jesse J., Guchelaar, Henk‐Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813171/ https://www.ncbi.nlm.nih.gov/pubmed/31250989 http://dx.doi.org/10.1002/psp4.12450

Ejemplares similares

Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
por: Yin, Anyue, et al.
Publicado: (2022)

Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
por: Yin, Anyue, et al.
Publicado: (2022)

Exposure–response analysis of endoxifen serum concentrations in early-breast cancer
por: Sanchez-Spitman, Anabel Beatriz, et al.
Publicado: (2020)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020)

Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
por: Zwart, Tom C., et al.
Publicado: (2022)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

Technologies for Pharmacogenomics: A Review
por: van der Lee, Maaike, et al.
Publicado: (2020)

Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy
por: Sanchez-Spitman, A. B., et al.
Publicado: (2018)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing
por: Yin, Anyue, et al.
Publicado: (2020)

Clonal Evolution and Therapeutic Resistance in Solid Tumors
por: Barrett, Michael T., et al.
Publicado: (2013)

Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study
por: Moes, Dirk Jan A. R., et al.
Publicado: (2021)

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation Setting
por: Zwart, Tom C., et al.
Publicado: (2021)

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle
por: van der Lee, Maaike, et al.
Publicado: (2021)

Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
por: van der Wouden, Cathelijne H., et al.
Publicado: (2022)

The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: van Gelder, Teun, et al.
Publicado: (2020)

Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors
por: Namazi, Hamidreza, et al.
Publicado: (2016)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007)

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
por: Zwart, Tom C., et al.
Publicado: (2020)

Flexible and Scalable Full‐Length CYP2D6 Long Amplicon PacBio Sequencing
por: Buermans, Henk P.J., et al.
Publicado: (2017)

Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients
por: Martial, Lisa C., et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
por: Centanni, Maddalena, et al.
Publicado: (2019)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
por: Sanchez Spitman, A. B., et al.
Publicado: (2017)

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
por: Sanchez-Spitman, A. B., et al.
Publicado: (2021)

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2018)

Evolution under Spatially Heterogeneous Selection in Solid Tumors
por: Li, Guanghao, et al.
Publicado: (2021)

Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients
por: Mosch, Romy, et al.
Publicado: (2022)

Mathematical Model of the Effect of Interstitial Fluid Pressure on Angiogenic Behavior in Solid Tumors
por: Phipps, Colin, et al.
Publicado: (2011)

International Workshop on Mathematical Modeling of Tumor-Immune Dynamics
por: Eladdadi, Amina, et al.
Publicado: (2014)

Evaluating cancer etiology and risk with a mathematical model of tumor evolution
por: Pénisson, Sophie, et al.
Publicado: (2022)

Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution
por: Liakopoulos, Apostolos, et al.
Publicado: (2022)

The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression
por: Habtemariam, Henok D., et al.
Publicado: (2022)

Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients
por: Liu, Xiaoyan, et al.
Publicado: (2016)

Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors
por: Varela, Ignacio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mu3sesvcvu3fd4jgrhd8reb3kj